FDA allowing at-home use of CapsoCam Plus

The FDA applied a labeling addendum for CapsoVision’s CapsoCam Plus, which will allow for at-home administration of the device.

Advertisement

CapsoCam Plus is a small bowel capsule endoscope. The labeling addendum will allow for fully remote capsule endoscopy procedures. The change will eliminate the need for in-person interaction between physicians and patients.

CapsoCam Plus is the only capsule endoscopy system that doesn’t require external equipment. The patient ingests the capsule, resumes daily activities while exam data is being captured, and returns the device eight to 12 hours later, where it will be disinfected between uses.

Physicians can use the CapsoCloud cloud-based software to review the images captured by the device.

More articles on healthcare:
Tennessee ASC introduces 2nd orthopedics robot — 5 details
ASC opens outside Boston with 4 joint owners — 4 things to know
Make your ASC’s anesthesia program more efficient: 5 strategies

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Building a High-Performance Cardiac PET Program: What Health Systems Should Consider

Thursday, July 30
12:00 PM - 1:00 PM CDT

Presenters: Rupa Sanghani, MD, FACC, FASNC, Rush University Medical CenterBrendon Loiselle, CDL Nuclear Technologies

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.